Skip to main content
Ulisse Biomed logo

Ulisse Biomed — Investor Relations & Filings

Ticker · UBM ISIN · IT0005451213 LEI · 815600F9C180B297BE35 XMIL Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2026-04-29 Declaration of Voting R…
Country IT Italy
Listing XMIL UBM

About Ulisse Biomed

https://www.ulissebiomed.com/

Ulisse Biomed is a healthcare biotechnology company specializing in distributed and connected diagnostic solutions. The company develops an integrated platform that includes miniaturized qPCR instruments, an AI-driven cloud-based software, and advanced multiplexing reagents. This technology enables genetic testing for a wide range of users, from large clinical and diagnostic laboratories to smaller, peripheral labs in industrial settings. Its primary markets are healthcare and diagnostics, serving hospitals and clinics, and the agrifood and nutraceutical sectors. The company also provides OEM and development services. In late 2025, shareholders approved a proposal to change the corporate name to Helyx Industries S.p.A.

Recent filings

Filing Released Lang Actions
L’ASSEMBLEA ORDINARIA DEGLI AZIONISTI HA: APPROVATO IL BILANCIO D’ESERCIZIO AL 31 DICEMBRE 2025; CONFERITO AD AUDIREVI S.P.A. L’INCARICO DI REVISIONE LEGALE DEI CONTI PER GLI ESERCIZI 2026-2028
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release summarizing the outcomes of the Annual General Meeting (Assemblea Ordinaria) held on 29 April 2026. It reports the shareholder votes: approval of the 2025 financial statements, allocation of loss, and appointment of the statutory auditor for 2026–2028. It does not include the full financial report itself but announces the voting results. This matches the Definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-29 Italian
RINVIO ASSEMBLEA ORDINARIA IN SECONDA CONVOCAZIONE
Regulatory Filings Classification · 1% confidence The document is a short regulatory press release (3,119 characters) announcing the postponement of the ordinary shareholders’ meeting (AGM) due to lack of quorum. It does not include any financial tables, voting results, management changes, or AGM presentation materials. It simply communicates a procedural update and provides links for further information. This fits best under the general fallback category for regulatory announcements that do not match any more specific filing type: Regulatory Filings (RNS).
2026-04-28 Italian
PUBBLICATA LA DOCUMENTAZIONE PER L’ASSEMBLEA ORDINARIA DEGLI AZIONISTI DEL 28 APRILE 2026, IN PRIMA CONVOCAZIONE, E OCCORRENDO, PER IL GIORNO 29 APRILE 2026, IN SECONDA CONVOCAZIONE
Report Publication Announcement Classification · 1% confidence The document is a brief press release notifying investors that the materials for the ordinary shareholders’ meeting (Assemblea Ordinaria) have been published on the company website and Borsa Italiana. It does not include the actual AGM materials themselves but simply announces their availability. Under the “menu vs meal” rule, this is an announcement of a report/publication rather than the report itself, fitting the Report Publication Announcement (RPA) category.
2026-04-13 Italian
CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA DEGLI AZIONISTI
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice (“convocazione”) convening the ordinary shareholders’ meeting (Assemblea ordinaria degli Azionisti), providing the meeting date(s), agenda items (approval of 2025 financial statements, profit allocation, appointment of auditor), record date, and procedural details for voting and questions. It is not the full annual report or minutes/results, but rather the proxy solicitation/information statement materials required to inform shareholders and solicit their attendance and votes. Therefore it is best classified as a Proxy Solicitation & Information Statement (PSI).
2026-04-11 Italian
IL CONSIGLIO DI AMMINISTRAZIONE APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025
Earnings Release Classification · 1% confidence The document is a press‐style announcement dated March 23, 2026 stating that the Board of Directors has approved the draft annual and consolidated financial statements for the year ended December 31, 2025. It provides summarized financial results (revenues, EBITDA, net loss, net financial position) and management commentary including guidance. Although it contains detailed figures, it is not the full audited annual report; rather, it is an initial public announcement of the company’s year-end results. This corresponds to an Earnings Release (ER). FY 2025
2026-03-23 Italian
NOMINA NUOVO SPECIALIST
Regulatory Filings Classification · 1% confidence The document is a press release from Helyx Industries announcing the appointment of a new 'Specialist' (market maker) for its shares on the Euronext Growth Milan exchange. This type of regulatory announcement regarding market operations and service provider changes does not fit into specific categories like M&A, dividends, or director dealings. Therefore, it falls under the general regulatory announcement category.
2026-03-10 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.